Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Arthritis, Rheumatoid (Phase 1)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma, Hepatocellular (Phase 1/Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Cholangiocarcinoma (Phase 1)
Colorectal Neoplasms (Phase 2)
Crohn Disease (Phase 1)
Diffuse Intrinsic Pontine Glioma (Phase 1)
Drugs, Investigational (Phase 1)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 3)
Glioblastoma (Phase 3)
Glioma (Phase 1/Phase 2)
Hamartoma (Phase 3)
HIV Infections (Phase 4)
Influenza, Human (Phase 1/Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 1)
Liver Cirrhosis, Alcoholic (Phase 3)
Lymphoma, Follicular (Phase 2)
Medulloblastoma (Phase 1/Phase 2)
Melanoma (Phase 2)
Mesothelioma (Phase 2/Phase 3)
Mesothelioma, Malignant (Phase 1)
Multiple Sclerosis (Phase 1)
Neoplasms (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 3)
Prostatic Neoplasms (Phase 1/Phase 2)
Rhabdomyosarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue